If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,110.00    -8.00 (-0.72%)
Bid:
1,100.00
Ask:
1,106.00
Spread: 6.00 (0.545%)
Market Cap: £380.03m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

AGM Statement

17 Nov 2020 07:00

RNS Number : 4950F
Craneware plc
17 November 2020
 

17 November 2020

 

Craneware plc

("Craneware" or the "Company")

 

AGM Statement

 

 

Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, is pleased to provide an update on trading ahead of its Annual General Meeting taking place at 10am today. The AGM will be run as a "closed meeting", with only the minimum required quorum of two shareholders being present as is necessary to enable the formal business of the meeting to be conducted.

 

The first four months of this fiscal year saw a return to strong sales growth, considerably ahead of the equivalent period of the prior year. Results are ahead of management expectations for this stage in the year and, we expect revenues and adjusted EBITDA for the Interim period to 31 December 2020 to be ahead of the equivalent period in the prior year, building the foundation for a return to double-digit growth in the future. We look forward to providing further details within our Trading Update for the 6 months ended 31 December 2020.

 

Our Value Cycle offering, delivered via our cloud-based Trisus platform, continues to resonate with the leadership teams of US hospitals. Trisus provides the means to collect, analyse, compare, verify, and correct their data, so they can improve the financial and operational performance of their hospitals, while improving patient outcomes.

 

With each hospital that joins the platform, Trisus becomes more powerful. Through the recent beta launches of the Trisus (cloud) versions of our core offerings, Chargemaster Toolkit and Pharmacy Chargelink, and our four live Trisus native cloud applications, we now have multiple means by which new and existing customers can join the Trisus Community, providing them with a gateway to the wider benefits the platform can provide.

 

We continue to see substantial new opportunities entering the sales pipeline and the Board is confident in the continued strong performance of the business.

 

 For further information, please contact:

Craneware plc

Peel Hunt 

Investec Bank

Alma

(NOMAD & Joint Broker)

(Joint Broker)

(Financial PR)

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)20 7597 5970

+44 (0)203 405 0205

Keith Neilson, CEO

Dan Webster

Patrick Robb

Caroline Forde

Craig Preston, CFO

George Sellar

Sebastian Lawrence

Robyn Fisher

Andrew Clark

Henry Reast

Helena BogleJoe Pederzolli

About Craneware

 

Craneware (AIM: CRW.L), the leader in automated value cycle solutions, collaborates with U.S. healthcare providers to plan, execute and monitor value-based economic performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's value cycle management suite includes charge capture, strategic pricing, patient engagement, claims analytics, revenue recovery and retention, and cost and margin intelligence solutions.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMBIBDBLGBDGGL
Date   Source Headline
14th Oct 20227:00 amRNSBlock listing Interim Review
11th Oct 20224:19 pmRNSHolding(s) in Company
10th Oct 202211:10 amRNSHolding(s) in Company
10th Oct 202211:02 amRNSHolding(s) in Company
23rd Sep 20229:06 amRNSVesting of Long Term Incentive Plan Awards
21st Sep 20224:14 pmRNSExercise of Share Options
20th Sep 20227:00 amRNSFinal Results
14th Sep 20223:29 pmRNSChange of Date of Final Results
26th Jul 20227:00 amRNSFY22 Trading Update and Notice of Results
7th Jul 20226:13 pmRNSHolding(s) in Company
27th Apr 20221:00 pmRNSBoard Appointment
14th Apr 202212:35 pmRNSBlock listing Interim Review
31st Mar 20224:09 pmRNSTotal Voting Rights
25th Mar 20222:16 pmRNSDividend Currency Election
22nd Mar 20221:37 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSDividend Payment Date Update
14th Mar 20227:00 amRNSInterim Results
7th Mar 20225:20 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSBlocklisting Application
31st Jan 20224:41 pmRNSSecond Price Monitoring Extn
31st Jan 20224:36 pmRNSPrice Monitoring Extension
31st Jan 20227:00 amRNSTrading Update and Notice of Results
26th Nov 20215:05 pmRNSDividend Currency Election
19th Nov 20212:46 pmRNSGrant of Long Term Incentive Plan Awards
16th Nov 20212:09 pmRNSResult of AGM
16th Nov 20217:00 amRNSAGM Statement and Integration Update
19th Oct 20217:00 amRNSPosting of Annual Report and Notice of AGM
15th Oct 20213:37 pmRNSBlock listing Interim Review
22nd Sep 202112:52 pmRNSPurchase of Shares
21st Sep 20215:58 pmRNSDividend Timetable
21st Sep 20217:00 amRNSFinal Results
20th Jul 20214:53 pmRNSHolding(s) in Company
14th Jul 20215:19 pmRNSHolding(s) in Company
13th Jul 20217:00 amRNSCompletion of SDS Holdco, Inc. Acquisition
13th Jul 20217:00 amRNSTrading Update and Notice of Results
18th Jun 202111:42 amRNSHolding(s) in Company
14th Jun 202110:01 amRNSHolding(s) in Company
10th Jun 202111:55 amRNSHolding(s) in Company
10th Jun 202111:53 amRNSDirector/PDMR Share Dealings
8th Jun 20214:40 pmRNSSecond Price Monitoring Extn
8th Jun 20214:35 pmRNSPrice Monitoring Extension
8th Jun 20212:05 pmRNSSecond Price Monitoring Extn
8th Jun 20212:00 pmRNSPrice Monitoring Extension
8th Jun 202111:05 amRNSSecond Price Monitoring Extn
8th Jun 202111:00 amRNSPrice Monitoring Extension
8th Jun 20219:05 amRNSSecond Price Monitoring Extn
8th Jun 20219:00 amRNSPrice Monitoring Extension
8th Jun 20217:00 amRNSResults of Placing and Total Voting Rights
7th Jun 20215:27 pmRNSProposed Placing
7th Jun 20215:25 pmRNSAcquisition of SDS Holdco, Inc.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.